Prospective Registry of Vertigo Due to Vertebrobasilar Transient Attacks.

NCT07421973 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-02-27

No results posted yet for this study

Summary

Vertigo and dizziness are common neurological complaints in the emergency department and may represent a wide spectrum of etiologies, including vertebrobasilar transient neurological attacks (VB-TNAs). Distinguishing VB-TNAs, particularly vertebrobasilar transient ischemic attacks (VB-TIAs), from migraine-like and other non-vascular conditions is often challenging at first presentation due to the absence of specific biomarkers and overlapping clinical features. The UTRAVERA study is a multicenter, prospective, observational investigation designed to characterize the clinical features of patients presenting with acute transient vertigo or dizziness suspected to be VB-TNAs. The study will also evaluate diagnostic evolution over time, treatment responses, and prognostic factors associated with clinical outcomes.

Conditions

  • Vertigo
  • Dizziness
  • TIA (Transient Ischemic Attack)
  • Transient Neurologic Symptoms

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER
  • University of Zurich

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • LMU Klinikum

    collaborator OTHER
  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Ji-Soo Kim, PhD · Seoul National University Bundang Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2028-05-30
Completion
2028-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07421973 on ClinicalTrials.gov